*In most patients, one LACRISERT® placed into each eye, once daily, is usually effective in providing all-day symptom relief.

Some patients may require twice daily use for optimal results.

 
 

The LACRISERT® insert softens within 1 hour and dissolves in 14 to 18 hours.

Based on pre-clinical data.

Patient Candidates

Your moderate to severe dry eye patients may benefit from LACRISERT® if they:


  • Remain symptomatic in spite of frequent use of artificial tears
  • Are unwilling to frequently apply artificial tears or use ointments or gels
  • Want to continue wearing contact lenses
  • Have undergone LASIK or cataract surgery
  • Suffer from dry eye symptoms secondary to Sjögren’s syndrome
Find Out More
Experts Chose LACRISERT®

Our featured eye doctors discuss topics like moderate to severe dry eye prevalence in their practices, why they choose LACRISERT®, and what patient types may benefit from treatment.

Paul Karpecki, OD

Koffler Vision Group

Doug Devries, OD

Eyecare Associates of Nevada

Jack Schaeffer, OD

Schaeffer Eye Center

Request LACRISERT® samples today

Request Samples You may be eligible to receive free samples. Click the link to sumbit your information.

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT® should be carefully followed.
  • If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery.
  • The following adverse reactions have been reported, but were in most instances mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

To report suspected adverse reactions, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or FDA.gov/medwatch.

Click here for full Prescribing Information

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT® should be carefully followed.

Important Safety Information

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.